Azita SalekiGerhardt - AbbVie Senior Vice President - Operations
| 4AB Stock | EUR 169.04 0.32 0.19% |
President
Dr. Azita SalekiGerhardt, Ph.D., is the Executive Vice President Operations of the Company. She served as Senior Vice President, Operations from 2013 to 2018. Dr. SalekiGerhardt served as Abbotts Vice President, Pharmaceuticals Manufacturing and Supply from 2011 to 2012, and as Divisional Vice President, Quality Assurance, Global Pharmaceutical Operations from 2008 to 2011. Dr. SalekiGerhardt joined Abbott in 1993. She serves on the board of Entegris Inc. since 2018.
| Age | 60 |
| Tenure | 7 years |
| Professional Marks | Ph.D |
| Phone | 847 932 7900 |
| Web | https://www.abbvie.com |
AbbVie Management Efficiency
The company has return on total asset (ROA) of 0.0991 % which means that it generated a profit of $0.0991 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.7239 %, meaning that it generated $0.7239 on every $100 dollars invested by stockholders. AbbVie's management efficiency ratios could be used to measure how well AbbVie manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 8 records | PRESIDENT Age | ||
| Mary Morris | Arrow Electronics | 60 | |
| Christopher Stansbury | Arrow Electronics | 53 | |
| Gretchen Zech | Arrow Electronics | 53 | |
| Sean Kerins | Arrow Electronics | 60 | |
| Lily Hughes | Arrow Electronics | 55 | |
| Andy King | Arrow Electronics | 55 | |
| Vincent Melvin | Arrow Electronics | 59 | |
| Chuck Kostalnick | Arrow Electronics | 53 | |
Management Performance
| Return On Equity | 0.72 | |||
| Return On Asset | 0.0991 |
AbbVie Inc Leadership Team
Elected by the shareholders, the AbbVie's board of directors comprises two types of representatives: AbbVie inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AbbVie. The board's role is to monitor AbbVie's management team and ensure that shareholders' interests are well served. AbbVie's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AbbVie's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Richard Gonzalez, Chairman of the Board, CEO | ||
| Perry Siatis, Gen VP | ||
| Thomas Hudson, VP Officer | ||
| Timothy Richmond, Senior Vice President - Human Resources | ||
| Laura Schumacher, Executive Vice President - Business Development, External Affairs, General Counsel | ||
| Robert Michael, Vice President Controller | ||
| Elizabeth Shea, VP Relations | ||
| Azita SalekiGerhardt, Senior Vice President - Operations | ||
| Jeffrey Stewart, Senior Vice President U.S. Commercial Operations | ||
| Scott Reents, VP CFO |
AbbVie Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AbbVie a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.72 | |||
| Return On Asset | 0.0991 | |||
| Profit Margin | 0.20 % | |||
| Operating Margin | 0.39 % | |||
| Current Valuation | 331.38 B | |||
| Shares Outstanding | 1.77 B | |||
| Shares Owned By Insiders | 0.12 % | |||
| Shares Owned By Institutions | 71.51 % | |||
| Price To Earning | 22.27 X | |||
| Price To Book | 18.07 X |
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Additional Information and Resources on Investing in AbbVie Stock
When determining whether AbbVie Inc is a strong investment it is important to analyze AbbVie's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact AbbVie's future performance. For an informed investment choice regarding AbbVie Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AbbVie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.